Cargando…

Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines

BACKGROUND: The objective of this study was to determine the rate of blood pressure control according to 4 sets of Canadian guidelines published over a decade in patients with diabetes mellitus attending Diabetes Centres in the province of Nova Scotia. METHODS: One hundred randomly selected charts f...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Cory, Dunbar, Peggy, Salisbury, Sonia, Sketris, Ingrid, Kephart, George
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1215496/
https://www.ncbi.nlm.nih.gov/pubmed/16033647
http://dx.doi.org/10.1186/1475-2840-4-11
_version_ 1782124959844270080
author Russell, Cory
Dunbar, Peggy
Salisbury, Sonia
Sketris, Ingrid
Kephart, George
author_facet Russell, Cory
Dunbar, Peggy
Salisbury, Sonia
Sketris, Ingrid
Kephart, George
author_sort Russell, Cory
collection PubMed
description BACKGROUND: The objective of this study was to determine the rate of blood pressure control according to 4 sets of Canadian guidelines published over a decade in patients with diabetes mellitus attending Diabetes Centres in the province of Nova Scotia. METHODS: One hundred randomly selected charts from each of 13 Diabetes Centres audited between 1997 and 2001 were extracted from the Diabetes Care Program of Nova Scotia Registry. Multivariate logistic regression analyses examined the relationship between individual characteristics and self-reported antihypertensive use. Included were 1132 adults, mean age 63 years (48% male), with 9 years mean time since diagnosis of diabetes. RESULTS: According to the 1992 guidelines, 63% of the patients and according to the 2003 guidelines, 84% of patients were above target blood pressure or receiving antihypertensive medications. Forty-seven percent of patients are considered to be hypertensive and not on treatment according to 2003 guidelines. The results of the multivariate analyses showed that the only factors independently associated with anti-hypertensive use was oral anti-hyperglycemic use. CONCLUSION: Hypertension is an additional risk factor in those with diabetes mellitus for macrovascular and microvascular complications. The health and budgetary impacts of addressing the treatment gap need to be further explored.
format Text
id pubmed-1215496
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12154962005-09-17 Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines Russell, Cory Dunbar, Peggy Salisbury, Sonia Sketris, Ingrid Kephart, George Cardiovasc Diabetol Methodology BACKGROUND: The objective of this study was to determine the rate of blood pressure control according to 4 sets of Canadian guidelines published over a decade in patients with diabetes mellitus attending Diabetes Centres in the province of Nova Scotia. METHODS: One hundred randomly selected charts from each of 13 Diabetes Centres audited between 1997 and 2001 were extracted from the Diabetes Care Program of Nova Scotia Registry. Multivariate logistic regression analyses examined the relationship between individual characteristics and self-reported antihypertensive use. Included were 1132 adults, mean age 63 years (48% male), with 9 years mean time since diagnosis of diabetes. RESULTS: According to the 1992 guidelines, 63% of the patients and according to the 2003 guidelines, 84% of patients were above target blood pressure or receiving antihypertensive medications. Forty-seven percent of patients are considered to be hypertensive and not on treatment according to 2003 guidelines. The results of the multivariate analyses showed that the only factors independently associated with anti-hypertensive use was oral anti-hyperglycemic use. CONCLUSION: Hypertension is an additional risk factor in those with diabetes mellitus for macrovascular and microvascular complications. The health and budgetary impacts of addressing the treatment gap need to be further explored. BioMed Central 2005-07-20 /pmc/articles/PMC1215496/ /pubmed/16033647 http://dx.doi.org/10.1186/1475-2840-4-11 Text en Copyright © 2005 Russell et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Russell, Cory
Dunbar, Peggy
Salisbury, Sonia
Sketris, Ingrid
Kephart, George
Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines
title Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines
title_full Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines
title_fullStr Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines
title_full_unstemmed Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines
title_short Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines
title_sort hypertension control: results from the diabetes care program of nova scotia registry and impact of changing clinical practice guidelines
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1215496/
https://www.ncbi.nlm.nih.gov/pubmed/16033647
http://dx.doi.org/10.1186/1475-2840-4-11
work_keys_str_mv AT russellcory hypertensioncontrolresultsfromthediabetescareprogramofnovascotiaregistryandimpactofchangingclinicalpracticeguidelines
AT dunbarpeggy hypertensioncontrolresultsfromthediabetescareprogramofnovascotiaregistryandimpactofchangingclinicalpracticeguidelines
AT salisburysonia hypertensioncontrolresultsfromthediabetescareprogramofnovascotiaregistryandimpactofchangingclinicalpracticeguidelines
AT sketrisingrid hypertensioncontrolresultsfromthediabetescareprogramofnovascotiaregistryandimpactofchangingclinicalpracticeguidelines
AT kephartgeorge hypertensioncontrolresultsfromthediabetescareprogramofnovascotiaregistryandimpactofchangingclinicalpracticeguidelines